drugset / Trial / NCT00160433
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to determine the safety and efficacy of 3 asoprisnil doses (0.5 mg, 1.5 mg, and 5.0 mg) for 12 weeks in women with endometriosis.
Timeline
- Start
- 2002-08
- Primary completion
- 2003-06
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asoprisnil | Other / unclassified | 0.5 mg | Oral |
| Subject | Asoprisnil | Other / unclassified | 1.5 mg | Oral |
| Subject | Asoprisnil | Other / unclassified | 5 mg | Oral |